Sutro Biopharma, Inc. (STRO)
37.69
+0.37
(+0.99%)
USD |
NASDAQ |
May 06, 16:00
37.60
-0.09
(-0.24%)
After-Hours: 20:00
Sutro Biopharma EPS Diluted (Quarterly) : -5.447 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AbbVie, Inc. | 0.3918 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | 0.54 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -46.76M |
| Revenue (Quarterly) | 11.65M |
| Total Expenses (Quarterly) | 58.41M |
| Enterprise Value | 718.20M |
| Gross Profit Margin (Quarterly) | 86.06% |
| Profit Margin (Quarterly) | -401.5% |
| Earnings Yield | -38.26% |
| Normalized Earnings Yield | -30.70 |